ロード中...
5PSQ-046 Direct-acting antivirals for hepatitis c virus in hiv co-infected patients
BACKGROUND: The development of new direct acting antivirals (DAAs) for hepatitis C virus (HCV) represents an evolution in the treatment. As HIV-HCV coinfection is common, evaluation of DAAs’ effectiveness and drug interactions with antiretroviral therapy (ART) is useful in this population. PURPOSE:...
保存先:
| 出版年: | Eur J Hosp Pharm |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Group
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535170/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.400 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|